{"id":"W2751269869","doi":"10.1136/annrheumdis-2017-211328","title":"Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"ca_institutions":"Southlake Regional Health Center","funders":"Janssen Research and Development; Regeneron Pharmaceuticals; Genentech; Celgene; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Rheumatoid arthritis; Placebo; Internal medicine; Adverse effect; Clinical endpoint; Rheumatology; Gastroenterology; Methotrexate; Arthritis; Clinical trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002050543,0.001635639,0.001617195,0.0002374143,0.0003066316,0.0009429294,0.0007457475,0.001206246,0.004153752],"category_scores_gemma":[0.0007054476,0.0003972612,0.001561297,0.0002986532,0.0004121358,0.0003672226,0.0004111753,0.001585058,0.001325034],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004921777,"about_ca_system_score_gemma":0.001170227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000636372,"about_ca_topic_score_gemma":0.001558386,"domain_scores_codex":[0.9995301,0.0002392327,0.00002691661,0.00005338752,0.00007755033,0.0000728814],"domain_scores_gemma":[0.9996399,0.00004795098,0.000100632,0.00003276659,0.00003666047,0.0001421032],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6944306,0.02695579,0.007057962,0.006433917,0.006691272,0.0003489309,0.0002169819,0.002462556,0.04408389,0.0009120824,0.0218679,0.1885382],"study_design_scores_gemma":[0.8800747,0.09065124,0.01255281,0.0001993929,0.001518845,0.00045474,0.00003666884,0.0008333073,0.00235729,0.0002151293,0.01106474,0.00004112226],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9190053,0.04944323,0.002628117,0.002201909,0.00064722,0.008124762,0.007698531,0.0004765576,0.009774311],"genre_scores_gemma":[0.9334291,0.02642306,0.006767624,0.005694415,0.0006942555,0.008207085,0.01075089,0.0001047992,0.007928718],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004153752,"threshold_uncertainty_score":0.01389569,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07247113780770482,"score_gpt":0.3915947864906373,"score_spread":0.3191236486829325,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}